NYSE:CHEHealthcare
How Barington’s Activist Push For Cost Cuts And Governance Changes At Chemed (CHE) Has Changed Its Investment Story
On July 21, 2026, Barington Capital escalated its campaign against Chemed, urging a strategic review, cost cuts including executive perks such as personal aircraft use and sporting-event tickets, and proposing a new director to address what it describes as weak oversight.
The activist’s claim that Chemed houses two strong but under-optimized businesses raises fresh questions about whether current management and board structures are fully unlocking their potential.
Next, we’ll examine how...